Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hyperion Therapeutics Inc.

Division of Horizon Therapeutics PLC
www.hyperiontx.com

Latest From Hyperion Therapeutics Inc.

Horizon's Poor Primary Care Performance Overshadows River Vision Buy

Horizon's deal to buy River Vision to bolster its orphan product pipeline is cast into the shade by a disappointing first quarter performance for its primary care business.

Deals Sales & Earnings

Raptor Buy Bolsters Horizon's Orphan Business As Primary Care Foots The Bill

Horizon will boost its orphan drug business through the acquisition of Raptor, using a combination of debt and cash from its primary care and other assets to fund the transaction.

Commercial Companies

Evotec Expands Sanofi Link With Exclusive Stem Cell Diabetes Deal

Evotec’s deal with the French drugmaker to develop stem cell-based treatments for diabetes takes on even more importance following the demise of the biotech’s two lead proprietary candidate therapies.

BioPharmaceutical Germany

Santen switches to pure ophthalmic business

Japanese firm Santen Pharmaceutical is reorganizing its business to have a sole focus on ophthalmology.

Japan Companies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Hepatic (Liver)
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Horizon Therapeutics PLC
  • Senior Management
  • Donald J Santel, CEO
    Jeffrey S Farrow, CFO
    Bruce F Scharschmidt, MD, CMO
    Christine A Nash, SVP, Chief Commercial Officer
  • Contact Info
  • Hyperion Therapeutics Inc.
    Phone: (650) 745-7802
    2000 Sierra Point Pkwy.
    Ste. 400
    Brisbane, CA 94005
    USA
UsernamePublicRestriction

Register